Authors: Zhang J; Department of Pharmacy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, P. R. China., Li L; Department of Pharmacy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, P. R. China., Yin J; Department of Pharmacy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, P. R. China., Zhang X; Department of Pharmacy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, P. R. China., Zheng Y; Department of Pharmacy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, P. R. China. zheng-ying-521@163.com., Feng R; Department of Pharmacy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, P. R. China. fengrui-125@163.com.

Source: BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2023 Mar 01; Vol. 24 (1), pp. 13. Date of Electronic Publication: 2023 Mar 01.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101590449 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-6511 (Electronic) Linking ISSN: 20506511 NLM ISO Abbreviation: BMC Pharmacol Toxicol Subsets: MEDLINE

Authors: Zhang X; Department of Thyroid and Breast III, Cangzhou Central Hospital, Cangzhou, Hebei, China., Li H; Department of Thyroid and Breast III, Cangzhou Central Hospital, Cangzhou, Hebei, China., Wu F; Department of Thyroid and Breast III, Cangzhou Central Hospital, Cangzhou, Hebei, China., Sun D; Department of Thyroid and Breast III, Cangzhou Central Hospital, Cangzhou, Hebei, China., Zhang H; Department of Thyroid and Breast III, Cangzhou Central Hospital, Cangzhou, Hebei, China/Graduate School of Hebei Medical University, Hebei, China., Jin L; Department of Thyroid and Breast III, Cangzhou Central Hospital, Cangzhou, Hebei, China., Kang X; Department of Ultrasound II, Cangzhou Central Hospital, Cangzhou, Hebei, China., Wang Z; Department of Thyroid and Breast III, Cangzhou Central Hospital, Cangzhou, Hebei, China.

Source: Pakistan journal of pharmaceutical sciences [Pak J Pharm Sci] 2023 Mar; Vol. 36 (2(Special)), pp. 619-623.

Publication Type: Journal Article

Journal Info: Publisher: Faculty of Pharmacy, University of Karachi Country of Publication: Pakistan NLM ID: 9426356 Publication Model: Print Cited Medium: Internet ISSN: 1011-601X (Print) Linking ISSN: 1011601X NLM ISO Abbreviation: Pak J Pharm Sci Subsets: MEDLINE

Authors: Chen Y; Cancer Institute, Xuzhou Medical University, Xuzhou, China., Han L; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China., Qiu X; Cancer Institute, Xuzhou Medical University, Xuzhou, China., Wang M; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China., Chen Z; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China., Cai Y; Cancer Institute, Xuzhou Medical University, Xuzhou, China., Xin Y; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China., Lv Y; Cancer Institute, Xuzhou Medical University, Xuzhou, China., Hu A; Center of Animal Laboratory, Xuzhou Medical University, Xuzhou, China., Chai D; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China., Li L; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China., Li H; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China., Zheng J; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China., Wang G; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China.

Source: Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 728-742.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print Cited Medium: Internet ISSN: 1521-0464 (Electronic) Linking ISSN: 10717544 NLM ISO Abbreviation: Drug Deliv Subsets: MEDLINE

Authors: Liu J; Department of Pharmacy., Zhang S; Department of Pharmacy., Yang F; The First Department of Respiratory Medical Oncology, Harbin Medical University Cancer Hospital, Harbin., Yin Y; Department of Pharmacy.; College of Pharmacy, Jiamusi University, Jiamusi, Heilongjiang, China., Yu J; Department of Pharmacy.; College of Pharmacy, Jiamusi University, Jiamusi, Heilongjiang, China., Cheng M; Department of Pharmacy., Yu Y; Department of Pharmacy., Jiang S; Department of Pharmacy., Dong M; Department of Pharmacy.; College of Pharmacy, Jiamusi University, Jiamusi, Heilongjiang, China.

Source: Anti-cancer drugs [Anticancer Drugs] 2023 Aug 01; Vol. 34 (7), pp. 837-843. Date of Electronic Publication: 2022 Nov 21.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE

MeSH Terms: Albumin-Bound Paclitaxel*/adverse effects , Genital Neoplasms, Female*/drug therapy , Genital Neoplasms, Female*/chemically induced, Female ; Humans ; East Asian People ; Chromatography, Liquid ; Tandem Mass Spectrometry ; Paclitaxel ; Albumins/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

Authors: Repp L; Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin, 53705, USA., Skoczen SL; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research Sponsored By the National Cancer Institute, Frederick, Maryland, 21702, USA., Rasoulianboroujeni M; Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin, 53705, USA., Stern ST; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research Sponsored By the National Cancer Institute, Frederick, Maryland, 21702, USA., Kwon GS; Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin, 53705, USA. glen.kwon@wisc.edu.

Source: The AAPS journal [AAPS J] 2023 Apr 11; Vol. 25 (3), pp. 39. Date of Electronic Publication: 2023 Apr 11.

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

MeSH Terms: Paclitaxel*/pharmacokinetics , Prodrugs*, Rats ; Mice ; Humans ; Animals ; Lactic Acid ; Micelles ; Albumin-Bound Paclitaxel ; Drug Carriers/pharmacokinetics ; Cell Line, Tumor ; Rats, Sprague-Dawley ; Polymers ; Polyesters

Authors: Zheng Q; Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China., Wang H; Pneumology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China., Xue C; Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China., Yang S; Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China., Wang Y; Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China., Hou W; Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China. houwei1964@163.com., Zhang Y; Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China. zylzy501@163.com.

Source: Scientific reports [Sci Rep] 2023 Jun 03; Vol. 13 (1), pp. 9028. Date of Electronic Publication: 2023 Jun 03.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

MeSH Terms: Albumin-Bound Paclitaxel*/therapeutic use , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology, Humans ; Female ; Retrospective Studies ; Paclitaxel/adverse effects ; Albumins/therapeutic use ; Creatine Kinase ; Creatine Kinase, MB Form

Authors: O'Donnell J; Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Zhao Z; Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Buckingham L; Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Hao T; Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Suo H; Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100006, P.R. China., Zhang X; Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100006, P.R. China., Fan Y; Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100006, P.R. China., John C; Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Deng B; Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Shen X; Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Sun W; Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Secord AA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University, Durham, NC 27705, USA., Zhou C; Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Bae-Jump VL; Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Source: International journal of oncology [Int J Oncol] 2023 Sep; Vol. 63 (3). Date of Electronic Publication: 2023 Jul 28.

Publication Type: Journal Article

Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE

Authors: Zhang X; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China., Chen J; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China., Liu N; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China., Wang Q; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China., Wu Q; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China., Gao F; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China., Sang Y; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China., Wang P; Department of Gynecology, People's Hospital of Zouping City, Binzhou, Shandong, People's Republic of China.

Source: Journal of cancer research and therapeutics [J Cancer Res Ther] 2022 Apr; Vol. 18 (2), pp. 482-487.

Publication Type: Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Medknow Publications Country of Publication: India NLM ID: 101249598 Publication Model: Print Cited Medium: Internet ISSN: 1998-4138 (Electronic) Linking ISSN: 19984138 NLM ISO Abbreviation: J Cancer Res Ther Subsets: MEDLINE

Authors: Suh KJ; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Gyeonggi-do, Republic of Korea., Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Zang DY; Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine, Anyang, Gyeonggi-do, Republic of Korea., Bae WK; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea., Lee HS; Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea., Oh HJ; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Gyeonggi-do, Republic of Korea., Kang M; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Gyeonggi-do, Republic of Korea., Kim JW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Gyeonggi-do, Republic of Korea., Kim BJ; Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine, Anyang, Gyeonggi-do, Republic of Korea., Mortimer PGS; Oncology R&D, AstraZeneca, Cambridge, UK., Kim HJ; Oncology R&D, AstraZeneca, Seoul, Korea., Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Gyeonggi-do, Republic of Korea.

Source: The oncologist [Oncologist] 2023 Sep 07; Vol. 28 (9), pp. e823-e834.

Publication Type: Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Authors: Wang S, Li H, Li M, Liu X, Yu S, Huang H, Wang X

Source: Alternative therapies in health and medicine [Altern Ther Health Med] 2023 Jul; Vol. 29 (5), pp. 132-140.

Publication Type: Journal Article

Journal Info: Publisher: InnoVision Communications Country of Publication: United States NLM ID: 9502013 Publication Model: Print Cited Medium: Print ISSN: 1078-6791 (Print) Linking ISSN: 10786791 NLM ISO Abbreviation: Altern Ther Health Med Subsets: MEDLINE

Authors: Yang X; Department of Pharmacology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China., Li C; Department of Pharmacology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China., Liao X; Department of Pharmacology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China., Liu S; Department of Pharmacology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China., Li X; Department of Pathology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, Guangdong 510006, P.R. China., Hou X; Department of Pathogen Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China., Wang K; Department of Pathology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, Guangdong 510006, P.R. China., Yang H; Department of Pathology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, Guangdong 510006, P.R. China., Gao L; Department of Obstetrics and Gynecology, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong 510632, P.R. China., Zhu L; Department of Pharmacology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China.

Source: Oncology reports [Oncol Rep] 2023 Jun; Vol. 49 (6). Date of Electronic Publication: 2023 Apr 21.

Publication Type: Journal Article

Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE

Authors: Liu Y; The Second Surgical Department of Breast Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China., Hong G; Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300192, China., Mao L; Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300192, China., Su Z; Tianjin Institute for Drug Control, Tianjin 300070, China., Liu T; Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300192, China., Liu H; The Second Surgical Department of Breast Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.

Source: Molecules (Basel, Switzerland) [Molecules] 2023 Apr 23; Vol. 28 (9). Date of Electronic Publication: 2023 Apr 23.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE

Authors: Liu X; Department of Anesthesiology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050051, People's Republic of China., Tang M; Department of General Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China., He TY; Department of Anesthesiology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050051, People's Republic of China., Zhao S; Department of Anesthesiology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050051, People's Republic of China., Li HZ; Department of Anesthesiology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050051, People's Republic of China., Li Z; Department of Anesthesiology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050051, People's Republic of China., Guo YX; Department of Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, People's Republic of China., Wang XL; Department of Anesthesiology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050051, People's Republic of China.

Source: Drug design, development and therapy [Drug Des Devel Ther] 2023 Apr 12; Vol. 17, pp. 1125-1138. Date of Electronic Publication: 2023 Apr 12 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE

Authors: Yuan J; Research Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai 201508, P.R. China., Guan W; Research Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai 201508, P.R. China., Li X; Research Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai 201508, P.R. China., Wang F; Research Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai 201508, P.R. China., Liu H; Research Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai 201508, P.R. China., Xu G; Research Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai 201508, P.R. China.

Source: International journal of oncology [Int J Oncol] 2023 Oct; Vol. 63 (4). Date of Electronic Publication: 2023 Aug 18.

Publication Type: Journal Article

Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE

Authors: Xie K, Liu L, Wang M, Li X, Wang B, Yin S, Chen W, Lin Y, Zhu X

Source: Acta biochimica et biophysica Sinica [Acta Biochim Biophys Sin (Shanghai)] 2023 Apr 28; Vol. 55 (4), pp. 623-632.

Publication Type: Journal Article

Journal Info: Publisher: China Science Publishing & Media Ltd Country of Publication: China NLM ID: 101206716 Publication Model: Print Cited Medium: Internet ISSN: 1745-7270 (Electronic) Linking ISSN: 16729145 NLM ISO Abbreviation: Acta Biochim Biophys Sin (Shanghai) Subsets: MEDLINE

Authors: Liang Y; The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, People's Republic of China.; Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, People's Republic of China., Wu G; Nanfang Hospital Baiyun Branch, Guangzhou, Guangdong, 510000, People's Republic of China., Luo T; The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, People's Republic of China.; Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, People's Republic of China., Xie H; Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, People's Republic of China., Zuo Q; Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, People's Republic of China., Huang P; Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, People's Republic of China., Li H; Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, People's Republic of China., Chen L; Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, People's Republic of China., Lu H; The First People's Hospital of Shaoguan, Shaoguan, Guangdong, 512099, People's Republic of China., Chen Q; The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, People's Republic of China.; Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, People's Republic of China.

Source: Drug design, development and therapy [Drug Des Devel Ther] 2023 Jan 20; Vol. 17, pp. 129-142. Date of Electronic Publication: 2023 Jan 20 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE

Authors: Liu B; College of Pharmacy, Jilin University, Changchun 130021, China., Liu S; Xuanwu Hospital Capital Medical University, Beijing 100053, China., Sun D; College of Pharmacy, Jilin University, Changchun 130021, China.

Source: Mediators of inflammation [Mediators Inflamm] 2023 Jan 27; Vol. 2023, pp. 5604103. Date of Electronic Publication: 2023 Jan 27 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Hindawi Pub. Corp Country of Publication: United States NLM ID: 9209001 Publication Model: eCollection Cited Medium: Internet ISSN: 1466-1861 (Electronic) Linking ISSN: 09629351 NLM ISO Abbreviation: Mediators Inflamm Subsets: MEDLINE

Authors: Huang H; Suzhou Medical College, Soochow University, 199 Ren'ai Road, Suzhou Industrial Park, Suzhou 215123, China.; Department of Pediatric Surgery, The First Affiliated Hospital of Gannan Medical University, 23 Qingnian Road, Ganzhou 341001, China., Huang H; School of Stomatology, Fuzhou Medical University, 9 Donglin Road, Fuzhou 344000, China., Sun Y; Division of Pharmaceutics, Jiangxi University of Traditional Chinese Medicine, 1688 Meiling Road, Nanchang 330004, China., Liu Q; Suzhou Medical College, Soochow University, 199 Ren'ai Road, Suzhou Industrial Park, Suzhou 215123, China.; Department of Pediatric Surgery, The First Affiliated Hospital of Gannan Medical University, 23 Qingnian Road, Ganzhou 341001, China.; School of Life Science, Jiangxi University of Traditional Chinese Medicine, 1688 Meiling Road, Nanchang 330004, China.

Source: Molecules (Basel, Switzerland) [Molecules] 2023 Jan 19; Vol. 28 (3). Date of Electronic Publication: 2023 Jan 19.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE

Authors: Sun W; Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, Shenzhen Nanshan People's Hospital and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China., Yang S; Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, Shenzhen Nanshan People's Hospital and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China., Wu S; Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, Shenzhen Nanshan People's Hospital and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China., Ba X; Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, Shenzhen Nanshan People's Hospital and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China.; School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China., Xiong D; Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, Shenzhen Nanshan People's Hospital and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China., Xiao L; Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, Shenzhen Nanshan People's Hospital and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China., Hao Y; School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China.

Source: Molecular pain [Mol Pain] 2023 Jan-Dec; Vol. 19, pp. 17448069221106167.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Sage Publications Inc Country of Publication: United States NLM ID: 101242662 Publication Model: Print Cited Medium: Internet ISSN: 1744-8069 (Electronic) Linking ISSN: 17448069 NLM ISO Abbreviation: Mol Pain Subsets: MEDLINE

Authors: Song J; School of Basic Medicine, Qingdao University, Ningxia Road 308, Qingdao, People's Republic of China., Cheng M; School of Basic Medicine, Qingdao University, Ningxia Road 308, Qingdao, People's Republic of China., Xie Y; School of Basic Medicine, Qingdao University, Ningxia Road 308, Qingdao, People's Republic of China., Li K; School of Basic Medicine, Qingdao University, Ningxia Road 308, Qingdao, People's Republic of China., Zang X; School of Basic Medicine, Qingdao University, Ningxia Road 308, Qingdao, People's Republic of China. zangxinlong@126.com.

Source: Journal of nanobiotechnology [J Nanobiotechnology] 2023 Mar 16; Vol. 21 (1), pp. 93. Date of Electronic Publication: 2023 Mar 16.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE